Nasal Delivery of CNS Therapeutics (R41/R42)


Funding Opportunity ID: 293443
Opportunity Number: RFA-DA-18-007
Opportunity Title: Nasal Delivery of CNS Therapeutics (R41/R42)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Category Explanation:
CFDA Number(s): 93.279
Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See Funding Announcement for the Eligibility Details
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Apr 25, 2017
Close Date: Aug 23, 2017
Last Updated Date: Apr 25, 2017
Award Ceiling:
Award Floor:
Estimated Total Program Funding:
Expected Number of Awards:
Description: The purpose of this Small Business Technology Transfer (STTR) RFA is to develop a nasal delivery formulation that reliably delivers of a therapeutic (e.g., peptides, antibodies, RNAi, or pharmacotherapeutics), at a physiologically relevant concentration, into the central nervous system (CNS).
Version: Synopsis 1

Source link


Please enter your comment!
Please enter your name here